LB Pharmaceuticals
1 follower
LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. The company's lead compound is LB-102; a novel benzamide being developed the treatment of schizophrenia owned and development internally by LB. LB-102 recently completed a Phase 1 study; a First-in-... Read more
Org chart
Zachary Prensky
Collapse
Andrew Vaino
Chief Scientific Officer
Marc Panoff
Chief Financial Officer
Anna Eramo
Chief Medical Officer
